Home › NDC Lookup › Labelers › Alexion Pharmaceuticals Inc.

Alexion Pharmaceuticals Inc. NDCs and Package Codes

This page lists NDC package records associated with labeler code 25682 (Alexion Pharmaceuticals Inc.) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

11
Package NDCs
12
Products
12
Active listings
0
Discontinued
5
Ingredients
0
Therapeutic classes
5
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
ASFOTASE ALFA 4
ravulizumab 3
ECULIZUMAB 2
Danicopan 2
Sebelipase alfa 1
By dosage form
SOLUTION 4
INJECTION, SOLUTION, CONCENTRATE 3
SOLUTION, CONCENTRATE 3
TABLET, FILM COATED 1
KIT 1

Browse records — 12 products

Drug / product Billing NDC NADAC / unit Status
KANUMA Sebelipase alfa 2 mg/mL INJECTION, SOLUTION, CONCENTRATE Alexion · NDC 25682-0007-01 · 1 VIAL, GLASS in 1 CARTON (25682-007-01) / 10 mL in 1 VIAL, GLASS 25682-0007-01 — Discontinued View →
SOLIRIS ECULIZUMAB 300 mg/30mL INJECTION, SOLUTION, CONCENTRATE Alexion · NDC 25682-0001-01 · J1299 · 1 VIAL in 1 CARTON (25682-001-01) / 30 mL in 1 VIAL 25682-0001-01 — On market View →
SOLIRIS ECULIZUMAB 300 mg/30mL INJECTION, SOLUTION, CONCENTRATE Alexion · NDC 25682-0001-01 · J1299 · 1 VIAL in 1 CARTON (25682-001-01) / 30 mL in 1 VIAL 25682-0001-01 — On market View →
STRENSIQ ASFOTASE ALFA 80 mg/.8mL SOLUTION Alexion · NDC 25682-0019-12 · 12 VIAL in 1 CARTON (25682-019-12) / .8 mL in 1 VIAL (25682-019-01) 25682-0019-12 — On market View →
STRENSIQ ASFOTASE ALFA 18 mg/.45mL SOLUTION Alexion · NDC 25682-0010-12 · 12 VIAL in 1 CARTON (25682-010-12) / .45 mL in 1 VIAL (25682-010-01) 25682-0010-12 — On market View →
STRENSIQ ASFOTASE ALFA 40 mg/mL SOLUTION Alexion · NDC 25682-0016-12 · 12 VIAL in 1 CARTON (25682-016-12) / 1 mL in 1 VIAL (25682-016-01) 25682-0016-12 — On market View →
STRENSIQ ASFOTASE ALFA 28 mg/.7mL SOLUTION Alexion · NDC 25682-0013-12 · 12 VIAL in 1 CARTON (25682-013-12) / .7 mL in 1 VIAL (25682-013-01) 25682-0013-12 — On market View →
Ultomiris ravulizumab 300 mg/30mL SOLUTION, CONCENTRATE Alexion · NDC 25682-0022-01 · 1 VIAL, GLASS in 1 CARTON (25682-022-01) / 30 mL in 1 VIAL, GLASS 25682-0022-01 — On market View →
Ultomiris ravulizumab 1100 mg/11mL SOLUTION, CONCENTRATE Alexion · NDC 25682-0028-01 · J1303 · 1 VIAL, GLASS in 1 CARTON (25682-028-01) / 11 mL in 1 VIAL, GLASS 25682-0028-01 — On market View →
Ultomiris ravulizumab 300 mg/3mL SOLUTION, CONCENTRATE Alexion · NDC 25682-0025-01 · J1303 · 1 VIAL, GLASS in 1 CARTON (25682-025-01) / 3 mL in 1 VIAL, GLASS 25682-0025-01 — On market View →
Voydeya Danicopan 100 mg/1 TABLET, FILM COATED Alexion · NDC 25682-0043-92 · 2 BOTTLE in 1 CARTON (25682-043-92) / 90 TABLET, FILM COATED in 1 BOTTLE 25682-0043-92 — On market View →
Voydeya Danicopan KIT Alexion · NDC 25682-0046-92 · 1 KIT in 1 CARTON (25682-046-92) * 90 TABLET, FILM COATED in 1 BOTTLE (25682-040-90) * 90 TABLET, FILM COATED in 1 BOTTLE (25682-043-90) 25682-0046-92 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.